BSX Insider Buying & Government Contracts (2026)

BSX insider buying and selling over the past year

Insiders at BOSTON SCIENTIFIC CORP only sold stock in the open market over the past year: 5 Form 4 sales totaling $24.35M, against no open-market purchases.

Most of the selling was pre-scheduled: 5 of the 5 sales (100.0%) were flagged as Rule 10b5-1 plan trades, which are set up in advance and say less about an insider's current view than discretionary sales. Activity clustered in 2025-11 (2 trades) and 2025-10 (1 trades); the latest filing in this window is dated 2026-02-02. The average open-market sale price was $95.86; the last close of $44.39 is 53.7% below that level, so sellers exited above the current price. The single largest trade was a sale of 160,901 shares worth $15.04M on 2026-02-02. Since the most recent filing the stock has moved -51.7%, from $91.87.

Where BSX trades relative to its one-year range

BOSTON SCIENTIFIC CORP closed at $44.39 on 2026-10-16, inside a one-year range of $41.58 to $104.98. That puts the stock near the bottom of its range, at 4.4% of the distance from low to high. Over one year the share price moved -54.6%, and over roughly three months +0.8%. Average daily volume over the last month was about 18,131,913 shares.

Across 83 companies in the same SEC industry group (SIC 38) with a full year of prices in Gemral Edge, the median one-year return was +13.2%. BSX is behind that median and beat 1% of that peer group on this measure.

Members of Congress who traded BSX

STOCK Act disclosures show 73 trades in BSX by 14 members of Congress over five years (30 purchases, 43 sales), most recently on 2026-09-11. The most active traders were Ro Khanna (D-CA), 30 trades; Gilbert Ray Cisneros, Jr. (D-CA), 18 trades; Kevin Hern (R-OK), 7 trades; Lisa C. McClain (R-MI), 5 trades; Bruce Westerman (R-AR), 2 trades.

By party the trades split 52 by Democrats, 21 by Republicans; by chamber, 68 from the House, 5 from the Senate.

BOSTON SCIENTIFIC CORP federal contract exposure

Federal procurement records resolve 2 prime award actions to BOSTON SCIENTIFIC CORP, worth $136.63M across 2 agencies. Department of Defense accounts for 99.3% of that value ($135.68M), so revenue from this channel depends heavily on one buyer.

BSX lobbying disclosures

BOSTON SCIENTIFIC CORP appears in 5 Lobbying Disclosure Act filings between 2018 and 2018, with $855.0K in reported lobbying spend.

Compare BSX with indexed peers from the same industry group

These peers have full Gemral Edge dossiers and the closest one-year price move to BSX:

• PODD one-year return -55.4%
• TRMB one-year return -23.6%
• ROP one-year return -23.5%
• SYK one-year return -20.2%
• NOC one-year return -13.2%

Sources and method

Every figure above is computed from public filings stored in Gemral Edge, not estimated. Insider figures count only open-market purchases and sales reported on SEC Form 4; option exercises, grants and gifts are excluded because they do not reflect a decision to buy or sell at market prices.

• SEC EDGAR Form 4 (edge_insider_trades, codes P/S open-market only) — as of 2026-02-02
• edge_prices_eod (end-of-day close) — as of 2026-10-16
• House PTR / Senate eFD disclosures (edge_congress_trades) — as of 2026-09-11
• FPDS / USAspending (edge_contracts, tier-1 resolved) — as of 2026-09-28
• Senate LDA filings (edge_lobbying_filings)

BSX data questions

Are BSX insiders buying or selling stock?

Insiders at BOSTON SCIENTIFIC CORP only sold stock in the open market over the past year: 5 Form 4 sales totaling $24.35M, against no open-market purchases.

What is the one-year price range for BSX?

Based on end-of-day closes through 2026-10-16, BSX traded between $41.58 and $104.98, last closing at $44.39.

Has any member of Congress traded BSX stock?

Yes. 14 members disclosed 73 trades in BSX over five years; the most recent disclosed trade date is 2026-09-11.